Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Hantusch

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
The Journal of Clinical Investigation|May 5, 2011
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouseDontscho Kerjaschki, Zsuzsanna Bago-Horvath, Margaretha Rudas, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.
The Journal of Clinical Investigation|May 5, 2011
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouseDontscho Kerjaschki, Zsuzsanna Bago-Horvath, Margaretha Rudas, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 3